title: Summary of recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction.
authors.affiliation: Centre Hospitalier Universitaire Pitié-Salpétrière, Paris, France. gilles.montalescot@psl.ap-hop-paris.fr
authors.forename: G
authors.initials: G
authors.lastname: Montalescot
authors.forename: H R
authors.initials: HR
authors.lastname: Andersen
authors.forename: D
authors.initials: D
authors.lastname: Antoniucci
authors.forename: A
authors.initials: A
authors.lastname: Betriu
authors.forename: M J
authors.initials: MJ
authors.lastname: de Boer
authors.forename: L
authors.initials: L
authors.lastname: Grip
authors.forename: F J
authors.initials: FJ
authors.lastname: Neumann
authors.forename: M T
authors.initials: MT
authors.lastname: Rothman
mesh_terms: D000077284:Abciximab; D000208:Acute Disease; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D008505:Medical Staff, Hospital; D009203:Myocardial Infarction / Q000188:drug therapy / Q000628:therapy*; D015425:Myocardial Reperfusion / Q000379:methods*; D017410:Practice Guidelines as Topic; D015607:Stents
chemical_list: D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D006493:Heparin; D000077284:Abciximab